Certolizumab Pegol for Treatment of Plaque Psoriasis: Pooled Three-Year Efficacy Outcomes from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2)
SKIN The Journal of Cutaneous Medicine(2020)
Abstract
Abstract not available.
MoreTranslated text
Key words
plaque psoriasis,treatment,three-year
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined